However, DPP-4is reportedly increases the risk of Alzheimer’s disease by aggravating tau phosphorylation and insulin resistance in the hippocampus and primary neurons of OLEF (Otsuka Long-Evans Tokushima Fatty) rats [22]. Here, MAPT is linked to Alzheimer disease.